Résumé
Using a clinically relevant, fully disparate, allogeneic aortic transplant mouse model of allograft vasculopathy, we have demonstrated that neointimal proliferation is dependent on CD8+ T cell effector pathways in the presence of therapeutic doses of calcineurin inhibitor (CNI) immunosuppression. CD4+ T cell pathways are ablated by CNI immunosuppression. In the current study, we examined the relationship between CD8+ T cell activities, medial SMC loss and neointimal hyperplasia.We demonstrate that at 5-6wk post transplantation in a wild type/wild type transplant CD8+ T cell infiltration, CD8+ CTL effector cell mediator expression and medial SMC loss all occur within aortic interposition grafts in the face of CNI immunosuppression. Both IFN-γ and CTL mediated effector function is required for SMC loss and lesion formation under these conditions. Using strain combinations and reconstitution models, we provide data that blockade of the perforin/granzyme pathway does not prevent lesion formation but that blockade of the Fas/FasL pathway of cytotoxicity dramatically reduces SMC loss and prevents neointimal lesion formation. Both of these blockade strategies are in the face of an active IFN-γ pathway. These data suggest a cooperative role between Fas/FasL and IFN-γ mediated effector functions in medial SMC loss and neointimal lesion formation.
Langue d'origine | English |
---|---|
Pages (de-à) | 157-164 |
Nombre de pages | 8 |
Journal | Transplant Immunology |
Volume | 22 |
Numéro de publication | 3-4 |
DOI | |
Statut de publication | Published - févr. 2010 |
Note bibliographique
Funding Information:The first author’s work is funded by the Irish Government Department of Culture, Heritage and the Gaeltacht under the GaelTech Project, and is also supported by Science Foundation Ireland in the ADAPT Centre (Grant 13/RC/2106) (http://www.adaptcentre.ie) at Dublin City University.
ASJC Scopus Subject Areas
- Immunology and Allergy
- Immunology
- Transplantation
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't